Who Owns Intensity Therapeutics Stock?
NASDAQ: INTSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 3:06 PM ET
Ownership breakdown
- Held by institutions
- 36.55%
- Held by insiders
- 3.92%
- Institutional holders
- 17
- Institutions 36.5%
- Insiders 3.9%
- Public and other 59.5%
Who owns Intensity Therapeutics stock?
Institutional investors own about 36.5% of Intensity Therapeutics's shares, spread across 17 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 3.92% of INTS.
The largest institutional holders are Kmt Wealth Management, LLC (15.21%), Kingsbury Capital Investment Advisors LLC (15.21%) and Rothschild Wealth, LLC (0.82%). Together, the top 10 institutions control 35.7% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their INTS positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of INTS
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Kmt Wealth Management, LLC | 496.49K | 15.21% | +100.0% |
| Kingsbury Capital Investment Advisors LLC | 496.49K | 15.21% | +1204.7% |
| Rothschild Wealth, LLC | 26.72K | 0.82% | +14.7% |
| Vanguard Capital Management LLC | 26.57K | 0.81% | +57.8% |
| Sapient Capital LLC | 26.01K | 0.80% | 0.0% |
| Nano Cap New Millennium Growth Fund L P | 25.00K | 0.77% | 0.0% |
| Geode Capital Management, LLC | 22.79K | 0.70% | -12.4% |
| FNY Investment Advisers, LLC | 22.00K | 0.67% | +100.0% |
| Mesirow Financial Investment Management, Inc. | 14.12K | 0.43% | 0.0% |
| Vanguard Fiduciary Trust Co | 9.12K | 0.28% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of INTS
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 26.57K | 0.81% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 11.73K | 0.36% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 3.25K | 0.10% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 3.09K | 0.09% |
Frequently asked questions
Who is the largest shareholder of Intensity Therapeutics?
Kmt Wealth Management, LLC is the largest institutional shareholder of INTS, owning 15.21% of shares outstanding (496.49K shares) as of its latest 13F filing.
What percentage of Intensity Therapeutics is owned by institutions?
Institutions own about 36.5% of INTS shares and 38.0% of the public float.
How much of Intensity Therapeutics do insiders own?
Insiders, such as officers and directors, own about 3.92% of INTS shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.